Sign in
4

Changes in Ownership

Lyell Immunopharma, Inc. Filed Acc 0001209191-22-020001

Options or other derivatives

  • Chief Technical Ops. Officer acquired 700,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hill Stephen J. · Chief Technical Ops. Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-03-16 Grant or award : show line 1 in the form Option (right to buy) +700,000 $5.98 2032-03-15 700,000 700,000 D
Loading xslF345X03/doc4.xml…